|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
US3901654A
(en)
|
1971-06-21 |
1975-08-26 |
Biological Developments |
Receptor assays of biologically active compounds employing biologically specific receptors
|
|
US3817827A
(en)
|
1972-03-30 |
1974-06-18 |
Scott Paper Co |
Soft absorbent fibrous webs containing elastomeric bonding material and formed by creping and embossing
|
|
US4098876A
(en)
*
|
1976-10-26 |
1978-07-04 |
Corning Glass Works |
Reverse sandwich immunoassay
|
|
US4704362A
(en)
*
|
1977-11-08 |
1987-11-03 |
Genentech, Inc. |
Recombinant cloning vehicle microbial polypeptide expression
|
|
FR2413974A1
(fr)
|
1978-01-06 |
1979-08-03 |
David Bernard |
Sechoir pour feuilles imprimees par serigraphie
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
EP0832981A1
(en)
*
|
1987-02-17 |
1998-04-01 |
Pharming B.V. |
DNA sequences to target proteins to the mammary gland for efficient secretion
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
JPH02262599A
(ja)
|
1989-01-03 |
1990-10-25 |
Merck & Co Inc |
ヒト多形核白血球からの精製Ｃ５ａレセプター
|
|
ES2096590T3
(es)
|
1989-06-29 |
1997-03-16 |
Medarex Inc |
Reactivos biespecificos para la terapia del sida.
|
|
US5633076A
(en)
*
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
|
US5284746A
(en)
|
1990-02-08 |
1994-02-08 |
Zymogenetics, Inc. |
Methods of producing hybrid G protein-coupled receptors
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
ATE158021T1
(de)
|
1990-08-29 |
1997-09-15 |
Genpharm Int |
Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5194594A
(en)
*
|
1990-09-07 |
1993-03-16 |
Techniclone, Inc. |
Modified antibodies
|
|
US5173414A
(en)
*
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
WO1992020373A1
(en)
|
1991-05-14 |
1992-11-26 |
Repligen Corporation |
Heteroconjugate antibodies for treatment of hiv infection
|
|
WO1993008829A1
(en)
|
1991-11-04 |
1993-05-13 |
The Regents Of The University Of California |
Compositions that mediate killing of hiv-infected cells
|
|
US5844094A
(en)
|
1992-09-25 |
1998-12-01 |
Commonwealth Scientific And Industrial Research Organization |
Target binding polypeptide
|
|
DK0752248T3
(da)
|
1992-11-13 |
2000-11-13 |
Idec Pharma Corp |
Terapeutisk anvendelse af kimæriske og radioaktivt mærkede antistoffer mod humant B-lymfocytbegrænset differentieringsantig
|
|
US5514555A
(en)
|
1993-03-12 |
1996-05-07 |
Center For Blood Research, Inc. |
Assays and therapeutic methods based on lymphocyte chemoattractants
|
|
US5480974A
(en)
|
1993-06-18 |
1996-01-02 |
The Scripps Research Institute |
Antibodies to human C5a receptor
|
|
US5827690A
(en)
*
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
|
US5861272A
(en)
*
|
1995-06-02 |
1999-01-19 |
Human Genome Sciences, Inc. |
C5A receptor
|
|
JPH08109200A
(ja)
|
1994-08-19 |
1996-04-30 |
Takeda Chem Ind Ltd |
抗Ｃ５ａレセプター抗体、その製造法および用途
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
AUPO591797A0
(en)
|
1997-03-27 |
1997-04-24 |
Commonwealth Scientific And Industrial Research Organisation |
High avidity polyvalent and polyspecific reagents
|
|
WO1996039511A2
(en)
|
1995-06-05 |
1996-12-12 |
Incyte Pharmaceuticals, Inc. |
A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR
|
|
JPH09124509A
(ja)
*
|
1995-10-27 |
1997-05-13 |
Sumitomo Electric Ind Ltd |
肝炎治療剤
|
|
CA2722378C
(en)
|
1996-12-03 |
2015-02-03 |
Amgen Fremont Inc. |
Human antibodies that bind tnf.alpha.
|
|
WO1998033908A1
(en)
|
1997-01-31 |
1998-08-06 |
Incyte Pharmaceuticals, Inc. |
Human c5a-like receptor
|
|
US8007798B2
(en)
*
|
1997-11-21 |
2011-08-30 |
Genentech, Inc. |
Treatment of complement-associated disorders
|
|
WO2002038767A2
(en)
|
2000-11-07 |
2002-05-16 |
Genetics Institute, Llc. |
G protein-coupled receptor protein and nucleic acid molecules and uses therefor
|
|
ES2389251T3
(es)
|
2000-12-19 |
2012-10-24 |
Altor Bioscience Corporation |
Animales transgénicos que comprenden un sistema inmunitario humanizado
|
|
WO2002061087A2
(en)
*
|
2000-12-19 |
2002-08-08 |
Lifespan Biosciences, Inc. |
Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
|
|
ES2283594T5
(es)
*
|
2001-08-17 |
2016-03-15 |
Genentech, Inc. |
Inhibidores de la ruta del complemento que se unen a C5 y C5a sin impedir la formación de C5b
|
|
CA2461917C
(en)
|
2001-09-27 |
2012-01-17 |
Merck & Co., Inc. |
Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
|
|
US7241444B2
(en)
*
|
2002-01-18 |
2007-07-10 |
Pierre Fabre Medicament |
Anti-IGF-IR antibodies and uses thereof
|
|
US8071096B2
(en)
|
2002-01-25 |
2011-12-06 |
G2 Therapies Ltd |
Anti-C5aR antibodies and uses thereof
|
|
EP1581648A2
(en)
|
2002-09-09 |
2005-10-05 |
Nura, Inc. |
G protein coupled receptors and uses thereof
|
|
DE10303664A1
(de)
*
|
2003-01-23 |
2004-08-12 |
Nemod Immuntherapie Ag |
Erkennungsmoleküle zur Behandlung und Detektion von Tumoren
|
|
WO2005060739A1
(en)
|
2003-12-24 |
2005-07-07 |
G2 Inflammation Pty Ltd |
Transgenic non-human mammal comprising a polynucleotide encoding human or humanized c5ar
|
|
WO2006037604A1
(en)
*
|
2004-10-01 |
2006-04-13 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Novel antibodies directed to the mammalian eag1 ion channel protein
|
|
ES2570153T3
(es)
|
2006-08-22 |
2016-05-17 |
Novo Nordisk As |
Anticuerpos anti-C5aR con propiedades mejoradas
|
|
JP2010501165A
(ja)
|
2006-08-22 |
2010-01-21 |
ジーツー インフラメイション プロプライエタリー リミテッド |
抗体の作製方法
|
|
RU2010138612A
(ru)
*
|
2008-02-20 |
2012-03-27 |
Джи2 ИНФЛЕММЕЙШН ПТИ ЛТД (AU) |
ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА ПРОТИВ C5аR
|